Nephrolithiasis or kidney stone disease is a condition characterized
by formation of calculi from chemicals such as calcium, oxalate, and
precipitate out of urine within the renal pelvis and tubular lumen.
According to data published by the National Institute of Diabetes and
Digestive and Kidney Diseases, nearly half a million people visit
emergency rooms and 3 million go to health care providers for kidney
stone problems in the U.S. each year, which puts significant economic
burden of over US$ 5.0 Bn. Treatment of kidney stone includes several
procedures such as shock wave lithotripsy (SWL), endoscopic
lithotripsy (ureteroscopy), percutaneous nephrolithotomy (PCNL), and
others. Ureteroscopic lithotripsy is a commonly used first line of
treatment for ureteral stones which fail to pass spontaneously and a
second line treatment in case of shock wave lithotripsy failure.
Despite several technological advancements in ureteroscopy procedure,
retropulsion or stone migration is one of the major complications
that leads to increased operative time. Anti-retropulsion devices are
used to prevent stone migration and positioned along with uteroscope
during ureteroscopic lithotripsy.
Request Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=35960
Rise in prevalence rates of nephrolithiasis, increase in geriatric
population which is prone to kidney stone disease, and cost
effectiveness of anti-retropulsion devices in ureteroscopic
lithotripsy when retropulsion rate is equal to or higher than 6.3%
are projected to augment the global anti-retropulsion devices market
during the forecast period. However, incidences of device recalls,
availability of non-invasive laser lithotripsy procedures, and
incidences of internal bleeding are factors likely to restrain the
global anti-retropulsion devices market.
The global anti-retropulsion devices market can be classified based
on product expansion width, end-user, and region. In terms of product
expansion width, the market can be bifurcated into 7–10 mm and
above 10 mm. Innovations in devices include cost effective design
enhancements such as expandable nitinol umbrella mesh and expandable
stainless steel and nitinol cone or braid. Several studies have shown
increased cost effectiveness, prevention of proximal stone migration,
and decreased operative time with the use of advanced
anti-retropulsion devices when compared with other options such as
use of lidocaine jelly. In terms of end-user, the global
anti-retropulsion devices market can be classified into hospitals,
specialty clinics, and ambulatory surgical centers.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=35960
The global anti-retropulsion devices market can be segmented into
five regions: North America, Europe, Asia Pacific, Latin America, and
Middle East & Africa. North America is projected to account for
major share of the global anti-retropulsion devices market in terms
of revenue during the forecast period owing to rise in prevalence of
kidney stone and lifestyle related diseases, technological
advancements in the field of ureteroscopy, and rise in preference for
ureteroscope technology in case of kidney stone procedures. However,
the market in Asia Pacific is likely to expand at a relatively faster
growth rate in terms of revenue during the forecast period driven by
significant patient population and rise in adoption of
technologically advanced devices.
Superior technological innovations such as dual-purpose devices that
combine functions of guide-wire function anti-retropulsion device
presents a major opportunity in the global anti-retropulsion devices
market during the forecast period. Increase in number of
collaborations and licensing agreements by major market players to
penetrate the relatively untapped market having low market entry
barriers along with high growth potential is a growing trend in the
global anti-retropulsion devices market.
Key players operating in the global anti-retropulsion devices market
are Boston Scientific Corporation, ROCAMED, Accordion Medical, and
Cook, among others.
About Us
Transparency Market Research is a next-generation market intelligence
provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with
ability to track more than one million high growth niche products are
aligned with your aims. The detailed and proprietary statistical
models used by our analysts offer insights for making right decision
in the shortest span of time. For organizations that require specific
but comprehensive information we offer customized solutions through
adhoc reports. These requests are delivered with the perfect
combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems
with right methodology of research is the key to help enterprises
reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment